DDAH I siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1Scientific reportsOctober 25, 2017Hulin JA, Tommasi S, Elliot D, Hu DG, Lewis BC, Mangoni AA.purchased from Shanghai GenePharma and transfected at 100 nM. Control siRNA and DDAH1-targeting siRNA (sc-105276; Santa Cruz Biotechnology) were transfected at 30 nM. Cell line maintenance and transfection The human

(2) Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginineArteriosclerosis, thrombosis, and vascular biologyJuly 1, 2011Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, et al.

DDAH I siRNA (h)